Sandoz’ EpiPen rival will launch in Q1, with lower price tag

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/CarrieCaptured)
(Image: Getty/CarrieCaptured)

Related tags: EpiPen, Sandoz, Generic drugs, Generics, Novartis, Medicine, Price, price increase

Sandoz will launch its epinephrine generic in early 2019 at a lower price point than rival generics on the market.

Sandoz, a division of Novartis, has updated its launch plans of Sympjepi (epinephrine) .3mg pre-filled single dose injection in the US; the injection will be available for the emergency treatment of allergic reactions, including anaphylaxis, in early Q1 2019.

The company stated that it is actively preparing to bring the product to the US market. With manufacturing already completed, it is well underway to establish an appropriate supply of the medicine for healthcare professionals and patients.

Sandoz set its planned wholesale cost for a two-pack of Sympjepi at $250 (€218), while Mylan’s and Teva’s authorized generic EpiPen products both retail for $300​.

Manufacturing of Teva’s generic began in August, following regulatory approval and will be in limited supply in the US upon launch.

Prices for the commonly prescribed EpiPen have been a subject of discussion, even at the level of US Congress​. In 2016, US Congress asked the US Food and Drug Administration for information on EpiPen generic submissions and processes, after Mylan increased its prices – that year, prices of the life-saving allergy drug-device increased by a total of 548%.

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers